Marx N - Search Results

1

Sodium-glucose cotransporter-2 inhibition for the reduction of cardiovascular events in high-risk patients with diabetes mellitus.

Marx N, McGuire DK. Marx N, et al. Eur Heart J. 2016 Nov 7;37(42):3192-3200. doi: 10.1093/eurheartj/ehw110. Epub 2016 May 5. Eur Heart J. 2016. PMID: 27153861 Review.

2

Cardiovascular effects of incretin-based therapies.

Lehrke M, Marx N. Lehrke M, et al. Among authors: marx n. Rev Diabet Stud. 2011 Fall;8(3):382-91. doi: 10.1900/RDS.2011.8.382. Epub 2011 Nov 10. Rev Diabet Stud. 2011. PMID: 22262075 Free PMC article. Review.

3

[Is hypoglycemia in diabetes type 2 a significant risk? Pro].

Marx N. Marx N. Dtsch Med Wochenschr. 2012 May;137(19):1007. doi: 10.1055/s-0031-1299025. Epub 2012 Apr 27. Dtsch Med Wochenschr. 2012. PMID: 22549259 German. No abstract available.

4

Cardiovascular effects of GLP-1 and GLP-1-based therapies: implications for the cardiovascular continuum in diabetes?

Burgmaier M, Heinrich C, Marx N. Burgmaier M, et al. Among authors: marx n. Diabet Med. 2013 Mar;30(3):289-99. doi: 10.1111/j.1464-5491.2012.03746.x. Diabet Med. 2013. PMID: 22804451 Review.

5

Should antidiabetic treatment of type 2 diabetes in patients with heart failure differ from that in patients without?

Gitt AK, Halle M, Hanefeld M, Kellerer M, Marx N, Meier JJ, Schumm-Draeger PM, Bramlage P, Tschöpe D. Gitt AK, et al. Among authors: marx n. Eur J Heart Fail. 2012 Dec;14(12):1389-400. doi: 10.1093/eurjhf/hfs136. Epub 2012 Sep 13. Eur J Heart Fail. 2012. PMID: 22977264 Free article. Review.

6

New antidiabetic therapies: innovative strategies for an old problem.

Lehrke M, Marx N. Lehrke M, et al. Among authors: marx n. Curr Opin Lipidol. 2012 Dec;23(6):569-75. doi: 10.1097/MOL.0b013e328359b19f. Curr Opin Lipidol. 2012. PMID: 23069986 Review.

7

C-peptide levels are associated with mortality and cardiovascular mortality in patients undergoing angiography: the LURIC study.

Marx N, Silbernagel G, Brandenburg V, Burgmaier M, Kleber ME, Grammer TB, Winkelmann BR, Boehm BO, März W. Marx N, et al. Diabetes Care. 2013 Mar;36(3):708-14. doi: 10.2337/dc12-1211. Epub 2012 Nov 30. Diabetes Care. 2013. PMID: 23204248 Free PMC article.

8

Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: rationale for the active-comparator CAROLINA trial.

Rosenstock J, Marx N, Kahn SE, Zinman B, Kastelein JJ, Lachin JM, Bluhmki E, Patel S, Johansen OE, Woerle HJ. Rosenstock J, et al. Among authors: marx n. Diab Vasc Dis Res. 2013 Jul;10(4):289-301. doi: 10.1177/1479164112475102. Epub 2013 Feb 28. Diab Vasc Dis Res. 2013. PMID: 23449634 Free article. Review.

9

Impact of type 2 diabetes mellitus and glucose control on fractional flow reserve measurements in intermediate grade coronary lesions.

Reith S, Battermann S, Hellmich M, Marx N, Burgmaier M. Reith S, et al. Among authors: marx n. Clin Res Cardiol. 2014 Mar;103(3):191-201. doi: 10.1007/s00392-013-0633-7. Epub 2013 Nov 22. Clin Res Cardiol. 2014. PMID: 24264473

10

Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.

de Ferranti SD, de Boer IH, Fonseca V, Fox CS, Golden SH, Lavie CJ, Magge SN, Marx N, McGuire DK, Orchard TJ, Zinman B, Eckel RH. de Ferranti SD, et al. Among authors: marx n. Circulation. 2014 Sep 23;130(13):1110-30. doi: 10.1161/CIR.0000000000000034. Epub 2014 Aug 11. Circulation. 2014. PMID: 25114208 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

593 results

Search Page